Credit card giant Mastercard (NYSE: MA) reported higher earnings and revenues for the second quarter, which also topped expectations. Second-quarter revenues increased 12% annually to $4.1 billion. The top-line growth was spurred by an 18% increase in switched transactions.
The Bottom-line
Adjusted earnings advanced to $1.89 per share from $1.66 per share in the second quarter of 2018. The bottom-line also came in above analysts’ forecast. Reported profit moved up to $2 billion or $2 per share from $1.6 billion or $1.5 per share a year earlier.
During the three-month period, both gross dollar volume and purchase volume increased by 13%. Contributing to the top-line growth, cross-border volumes grew 16% on a local currency basis. There was a 23% growth in other revenues, supported by the company’s Cyber & Intelligence and Data & Services solutions, which was partially offset by rebates and incentives.
Also read: MasterCard Q1 2019 Earnings Conference Call Transcript
CEO Ajay Banga said, “We are driving growth in our core products with key wins around the globe, and our recent acquisitions, such as Transfast, and new partnerships, like P27 in the Nordics, will help us address our customers’ evolving payments needs, particularly in the areas of real-time account-to-account and cross-border payments.”
Stock Buyback
During the quarter, the management repurchased 7.7 million shares for about $1.9 billion and paid $337 million in dividends. As of June 30, 2019, there were a total of 2.6 billion Mastercard and Maestro-branded cards issued to the company’s customers.
Competitors
Earlier this month, Visa (V) reported double-digit growth for third-quarter earnings and revenues to $1.37 per share and $5.84 billion respectively, which also surpassed analysts’ estimates. However, the stock suffered as the management slashed its full-year outlook.
Mastercard stock made steady gains so far this year and is currently trading at a record high of around $280. It has moved up 39% in the past twelve months, outperforming Visa and the S&P 500 index. The stock closed the last trading session lower.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on